Search results for "Menopause"
Aspects of pregnancy, menstruation associated with higher CVD risk in later life
Results agreed with some, but not all, previous studies that reported that early menarche was associated with an increased risk of cardiovascular disease (CVD).
https://immattersacp.org/weekly/archives/2018/01/23/4.htm
23 Jan 2018
Action, advocacy, partnering for falls
Partnering with patients can make a big difference in preventing falls, which can result in lingering disability.
https://immattersacp.org/archives/2018/03/action-advocacy-partnering-for-falls.htm
1 Mar 2018
Boxed warning removed from asthma drugs
This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2018/03/boxed-warning-removed-from-asthma-drugs.htm
1 Mar 2018
Endogenous sex hormone levels associated with CVD in postmenopausal women
Researchers used data from women participating in the Multi-Ethnic Study of Atherosclerosis (MESA) who did not have cardiovascular disease and had levels of testosterone, estradiol, dehydroepiandrosterone, and sex hormone binding globulin measured at baseline.
https://immattersacp.org/weekly/archives/2018/06/05/1.htm
5 Jun 2018
Recommendations issued for diagnosing, managing depression during menopause
Women with past major depressive episodes and women with severe depressive symptoms and/or suicidal ideation should always be evaluated for a mood disorder, among other recommendations.
https://immattersacp.org/weekly/archives/2018/09/11/2.htm
11 Sep 2018
New warning on SGLT2 inhibitors, REMS approved
This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2018/11/new-warning-on-sglt2-inhibitors-rems-approved.htm
1 Nov 2018
More recalls, information on impurity found in ARBs
This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2019/01/more-recalls-information-on-impurity-found-in-arbs.htm
1 Jan 2019
Guideline recommends pharmacologic treatment of osteoporosis in postmenopausal women at high fracture risk
Bisphosphonates are recommended for initial treatment, although ibandronate is not recommended for reducing nonvertebral or hip fracture risk, the clinical practice guideline from the Endocrine Society stated.
https://immattersacp.org/weekly/archives/2019/04/02/4.htm
2 Apr 2019
Resist the urge to overtreat bacteriuria
Antibiotics could be avoided more frequently even in patients who have significant bacteriuria if a physician takes the time to convey potential antibiotic risks.
https://immattersacp.org/archives/2019/07/resist-the-urge-to-overtreat-bacteriuria.htm
1 Jul 2019
Menopausal hormone therapy linked to breast cancer risk
An individual patient-level meta-analysis found that risk for breast cancer increased steadily with duration of use for all types of menopausal hormone therapy except vaginal estrogen and that risk was higher with estrogen-progestogen than estrogen-only formulations.
https://immattersacp.org/weekly/archives/2019/09/10/1.htm
10 Sep 2019